• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在肝癌中,NCAPG通过SIP依赖的β-连环蛋白泛素化调控促进上皮-间质转化。

NCAPG promotes epithelial-mesenchymal transition through SIP-dependent ubiquitination regulation of β-catenin in hepatocellular carcinoma.

作者信息

Wang Jiakun, He Aoxiao, Huang Zhihao, Lu Hongcheng, Xiong Jianghui, Wu Rongshou, Feng Qian, Ge Jin, Lei Jun, Li Enliang, Wu Linquan, Zhou Fan, Liao Wenjun

机构信息

Department of General Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, China.

Department of Emergency, The Second Affiliated Hospital, The Second Affiliated Hospital Jiangxi Medical College, Nanchang University, China.

出版信息

Cell Signal. 2025 Oct;134:111953. doi: 10.1016/j.cellsig.2025.111953. Epub 2025 Jun 18.

DOI:10.1016/j.cellsig.2025.111953
PMID:40541817
Abstract

Epithelial to mesenchymal transition (EMT) is known to play a critical role in tumor metastasis, and this is an obstacle for hepatocellular carcinoma (HCC) treatment. Here, we found that NCAPG, a non-SMC subunit in the concentrate I complex, was upregulated in tumor tissues in HCC patients and was correlated with a poor prognosis. We also found that NCAPG could promote EMT though restraining the ubiquitination of β-catenin in HCC in vitro and in vivo. Through Immunoprecipitation-mass spectrometry (IP-MS) and Co-immunoprecipitation (Co-IP) assays, we found that NCAPG might interact with SIP, which is the central component in the E3 ubiquitin ligase composed by Siah1-SIP-Skp1-Ebi. Mechanistically, NCAPG could weaken the stability of this E3 ubiquitin ligase though competitive binding with SIP,and this was the important factor for ubiquitination of β-catenin suppression. When NCAPG was upregulated, the stability of this E3 ubiquitin ligase declined because the interactions between Siah1/SIP and SIP/Skp1 were weakened. The opposite phenomenon occurred when NCAPG was downregulated. Furthermore, we discovered that the disordered domain of NCAPG (D-NCAPG) serves as the specific binding sites for SIP binding. In conclusion, this study reveals the underlying mechanism by which NCAPG promotes EMT in HCC, which may be useful in the treatment of NCAPG-expressing HCC.

摘要

上皮-间质转化(EMT)在肿瘤转移中起着关键作用,这是肝细胞癌(HCC)治疗的一个障碍。在此,我们发现浓缩物I复合物中的非SMC亚基NCAPG在HCC患者的肿瘤组织中上调,且与预后不良相关。我们还发现,NCAPG在体外和体内均可通过抑制HCC中β-连环蛋白的泛素化来促进EMT。通过免疫沉淀-质谱(IP-MS)和免疫共沉淀(Co-IP)分析,我们发现NCAPG可能与SIP相互作用,SIP是由Siah1-SIP-Skp1-Ebi组成的E3泛素连接酶的核心成分。从机制上讲,NCAPG可通过与SIP竞争性结合来削弱该E3泛素连接酶的稳定性,这是抑制β-连环蛋白泛素化的重要因素。当NCAPG上调时,由于Siah1/SIP与SIP/Skp1之间的相互作用减弱,该E3泛素连接酶的稳定性下降。当NCAPG下调时,情况则相反。此外,我们发现NCAPG的无序结构域(D-NCAPG)是SIP结合的特异性位点。总之,本研究揭示了NCAPG在HCC中促进EMT的潜在机制,这可能对治疗表达NCAPG的HCC有用。

相似文献

1
NCAPG promotes epithelial-mesenchymal transition through SIP-dependent ubiquitination regulation of β-catenin in hepatocellular carcinoma.在肝癌中,NCAPG通过SIP依赖的β-连环蛋白泛素化调控促进上皮-间质转化。
Cell Signal. 2025 Oct;134:111953. doi: 10.1016/j.cellsig.2025.111953. Epub 2025 Jun 18.
2
MARCH5 promotes hepatocellular carcinoma progression by inducing p53 ubiquitination degradation.MARCH5 通过诱导 p53 泛素化降解促进肝癌进展。
J Cancer Res Clin Oncol. 2024 Jun 11;150(6):303. doi: 10.1007/s00432-024-05782-7.
3
Tripartite motif 8 promotes the progression of hepatocellular carcinoma via mediating ubiquitination of HNF1α.三结构域蛋白 8 通过介导 HNF1α 的泛素化促进肝细胞癌的进展。
Cell Death Dis. 2024 Jun 15;15(6):416. doi: 10.1038/s41419-024-06819-y.
4
MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation.MET通过促进TRIB3介导的FOXO1降解来促进肝细胞癌的发展。
Clin Mol Hepatol. 2025 Jul;31(3):1032-1057. doi: 10.3350/cmh.2024.1163. Epub 2025 Apr 11.
5
Disrupting CCDC137-mediated LZTS2 and β-TrCP interaction in the nucleus inhibits hepatocellular carcinoma development via β-catenin and AKT.破坏细胞核中CCDC137介导的LZTS2与β-TrCP的相互作用可通过β-连环蛋白和AKT抑制肝细胞癌的发展。
Cell Death Differ. 2025 Jan;32(1):134-148. doi: 10.1038/s41418-024-01328-z. Epub 2024 Jun 25.
6
The scaffold protein DLG4 facilitates RNF63-mediated ubiquitination and degradation of STAT3 in non-small cell lung cancer.支架蛋白DLG4促进RNF63介导的非小细胞肺癌中STAT3的泛素化和降解。
Cell Commun Signal. 2025 Jul 6;23(1):325. doi: 10.1186/s12964-025-02334-5.
7
Chromosome 8q24 amplification associated with human hepatocellular carcinoma predicts MYC/ZEB1/MIZ1 transcriptional regulation.8q24 染色体扩增与人类肝细胞癌相关,预测 MYC/ZEB1/MIZ1 转录调控。
Sci Rep. 2024 Oct 18;14(1):24488. doi: 10.1038/s41598-024-75219-1.
8
Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.Fbxw7通过Notch1信号通路调控肝细胞癌的迁移和侵袭。
Int J Oncol. 2015 Jul;47(1):231-43. doi: 10.3892/ijo.2015.2981. Epub 2015 May 4.
9
Transglutaminase 2 Stimulates Cell Proliferation and Modulates Transforming Growth Factor-Beta Signaling Pathway Independently of Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.转谷氨酰胺酶2刺激肝癌细胞增殖并独立于上皮-间质转化调节转化生长因子-β信号通路。
Int J Mol Sci. 2025 Jun 8;26(12):5497. doi: 10.3390/ijms26125497.
10
GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma.GULP1作为肝细胞癌一种新型的诊断和预测生物标志物
Clin Mol Hepatol. 2025 Feb 6. doi: 10.3350/cmh.2024.1038.